State Street’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-137,728
| Closed | -$281K | – | 4876 |
|
|
2021
Q3 | $281K | Buy |
137,728
+8,100
| +6% | +$18.9K | ﹤0.01% | 4228 |
|
|
2021
Q2 | $385K | Sell |
129,628
-614,515
| -83% | -$1.62M | ﹤0.01% | 3958 |
|
|
2021
Q1 | $2.05M | Buy |
744,143
+55,741
| +8% | +$168K | ﹤0.01% | 3427 |
|
|
2020
Q4 | $1.67M | Sell |
688,402
-34,850
| -5% | -$84K | ﹤0.01% | 3427 |
|
|
2020
Q3 | $1.52M | Sell |
723,252
-14,051
| -2% | -$47.4K | ﹤0.01% | 3304 |
|
|
2020
Q2 | $2.79M | Sell |
737,303
-19,637
| -3% | -$58.8K | ﹤0.01% | 3048 |
|
|
2020
Q1 | $1.43M | Buy |
756,940
+80,569
| +12% | +$209K | ﹤0.01% | 3198 |
|
|
2019
Q4 | $1.41M | Buy |
676,371
+41,284
| +7% | +$79.2K | ﹤0.01% | 3347 |
|
|
2019
Q3 | $1.52M | Buy |
635,087
+63,759
| +11% | +$171K | ﹤0.01% | 3303 |
|
|
2019
Q2 | $1.79M | Buy |
571,328
+484,843
| +561% | +$1.78M | ﹤0.01% | 3282 |
|
|
2019
Q1 | $431K | Sell |
86,485
-2,678
| -3% | -$13.2K | ﹤0.01% | 3464 |
|
|
2018
Q4 | $399K | Buy |
89,163
+4,454
| +5% | +$21.7K | ﹤0.01% | 3479 |
|
|
2018
Q3 | $411K | Buy |
84,709
+66,495
| +365% | +$340K | ﹤0.01% | 3502 |
|
|
2018
Q2 | $109K | Sell |
18,214
-356,429
| -95% | -$2.61M | ﹤0.01% | 3623 |
|
|
2018
Q1 | $3.32M | Buy |
374,643
+180,874
| +93% | +$1.35M | ﹤0.01% | 2968 |
|
|
2017
Q4 | $1.4M | Buy |
193,769
+84,666
| +78% | +$529K | ﹤0.01% | 3282 |
|
|
2017
Q3 | $754K | Buy |
109,103
+46,997
| +76% | +$324K | ﹤0.01% | 3428 |
|
|
2017
Q2 | $443K | Buy |
+62,106
| New | +$287K | ﹤0.01% | 3433 |
|
State Street's SBBP Position: Q4 2021 in Review
State Street sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 137,728 shares — an estimated $281K sold.
State Street first reported a position in SBBP in Q2 2017 and held it in 18 quarters. The position peaked at $3.32M in Q1 2018. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.
- State Street reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
- State Street sold 137,728 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $281K.
- State Street first reported a position in Strongbridge Biopharma plc. in Q2 2017 and held it in 18 quarters.
- State Street's Strongbridge Biopharma plc. position peaked at $3.32M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.
Based on State Street's 13F filing for Q4 2021, filed 14 Feb 2022.